4 ms·
No, it seems like a very good reason to take useful/promising but improperly commercialized research and turn it into a product. A startup rarely has enough run
by diego 16y ago
No, it seems like a very good reason to take useful/promising but improperly commercialized research and turn it into a product. A startup rarely has enough runway to do the scientific research needed to solve a problem like this.
- snikolov 16y agoIt is certainly rare, but Numenta has been doing it for the past 6 years, and for several years before that at the Redwood Neuroscience Institute from which it spun off. In doing so, Numenta undoubtedly stands on the foundation of significant progress in academia, but still has to do a fair bit of what one might call "research engineering."